MedTrace Logo

Comparing Effectiveness of Merocel and Packing With Tranexamic Acid in the Management of Anterior Epistaxis

NCT03360045 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 135

Last updated 2018-08-07

No results posted yet for this study

Summary

Aim of this study is evaluate whether superior nasal compression with tranexamic acid to simple nasal compression and Merocel packing.

In this study, patients who presented with non-traumatic anterior epistaxis to emergency departments will be included in this study. Three different therapy option are created; first, nasal compression with tranexamic acid, second, simple nasal compression without any drugs. And third, packing with Merocel.

Conditions

Interventions

DRUG

Tranexamic Acid

500mg tranexamic acid is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.

DRUG

Normal saline

5 cc normal saline is sprayed in the nose by atomizer spray, and then is applied nasal compression by manually.

DEVICE

Merocel

Merocel packing is applied.

Sponsors & Collaborators

  • Kecioren Education and Training Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-01
Primary Completion
2018-08-01
Completion
2018-08-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03360045 on ClinicalTrials.gov